STOCK TITAN

[Form 4] Liquidia Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Liquidia Corporation (LQDA) – Form 4 insider filing

Director Dr. Joanna Horobin reported the grant of 18,396 restricted stock units (RSUs) on 17 June 2025. The award was coded “A”, indicating an acquisition from the issuer rather than an open-market purchase. The RSUs convert to common stock on a one-for-one basis and will vest on the earlier of (i) one year from the grant date or (ii) the day prior to Liquidia’s next annual shareholder meeting. Following the transaction, Dr. Horobin’s total beneficial ownership increased to 38,755 shares. No cash was exchanged (price reported as $0), and no derivative securities were involved beyond the RSU grant.

The filing represents routine annual director equity compensation and does not disclose any additional purchases, sales, or option exercises.

Liquidia Corporation (LQDA) – Comunicazione interna Form 4

La direttrice Dott.ssa Joanna Horobin ha segnalato la concessione di 18.396 unità di azioni vincolate (RSU) il 17 giugno 2025. Il premio è stato codificato come “A”, indicando un’acquisizione dall’emittente e non un acquisto sul mercato aperto. Le RSU si convertono in azioni ordinarie con un rapporto uno a uno e matureranno alla prima delle seguenti condizioni: (i) un anno dalla data di concessione oppure (ii) il giorno precedente all’assemblea annuale degli azionisti di Liquidia. Dopo la transazione, la proprietà effettiva totale della Dott.ssa Horobin è salita a 38.755 azioni. Non è stato scambiato denaro (prezzo indicato pari a 0 $) e non sono stati coinvolti strumenti derivati oltre alla concessione delle RSU.

La comunicazione rappresenta una normale compensazione azionaria annuale per il direttore e non riporta ulteriori acquisti, vendite o esercizi di opzioni.

Liquidia Corporation (LQDA) – Presentación interna Formulario 4

La directora Dra. Joanna Horobin reportó la concesión de 18,396 unidades de acciones restringidas (RSU) el 17 de junio de 2025. La adjudicación fue codificada como “A”, lo que indica una adquisición del emisor y no una compra en el mercado abierto. Las RSU se convierten en acciones ordinarias en una proporción uno a uno y se consolidarán en la fecha que ocurra primero entre (i) un año desde la fecha de concesión o (ii) el día anterior a la próxima junta anual de accionistas de Liquidia. Tras la transacción, la propiedad total beneficiaria de la Dra. Horobin aumentó a 38,755 acciones. No se intercambió efectivo (precio reportado como $0) y no se involucraron valores derivados más allá de la concesión de las RSU.

La presentación representa la compensación anual rutinaria en acciones para directores y no revela compras, ventas o ejercicios de opciones adicionales.

Liquidia Corporation (LQDA) – 내부자 신고서 Form 4

이사 조안나 호로빈 박사가 2025년 6월 17일에 18,396개의 제한 주식 단위(RSU) 부여를 보고했습니다. 이 수여는 “A”로 분류되었으며, 이는 공개 시장에서의 구매가 아닌 발행자로부터의 취득을 의미합니다. RSU는 1대1 비율로 보통주로 전환되며, 부여일로부터 1년이 경과하거나 Liquidia의 다음 연례 주주총회 전날 중 빠른 날에 권리가 확정됩니다. 이번 거래 후 호로빈 박사의 총 실질 소유 주식 수는 38,755주로 증가했습니다. 현금 거래는 없었으며(보고된 가격은 0달러), RSU 부여 외에 파생 증권은 포함되지 않았습니다.

이번 신고는 정기적인 이사 연간 주식 보상에 해당하며, 추가 매수, 매도 또는 옵션 행사 내역은 포함하지 않습니다.

Liquidia Corporation (LQDA) – Déclaration d’initié Formulaire 4

La directrice Dr Joanna Horobin a déclaré la attribution de 18 396 unités d’actions restreintes (RSU) le 17 juin 2025. Cette attribution a été codée « A », indiquant une acquisition auprès de l’émetteur plutôt qu’un achat sur le marché libre. Les RSU se convertissent en actions ordinaires à raison d’une action pour une unité et seront acquises au plus tôt entre (i) un an à compter de la date d’attribution ou (ii) la veille de la prochaine assemblée annuelle des actionnaires de Liquidia. Suite à cette opération, la détention bénéficiaire totale de Dr Horobin est passée à 38 755 actions. Aucun échange d’argent n’a eu lieu (prix déclaré à 0 $), et aucun instrument dérivé n’a été impliqué en dehors de l’attribution des RSU.

Cette déclaration correspond à une rémunération annuelle courante en actions pour les administrateurs et ne révèle aucun achat, vente ou exercice d’option supplémentaire.

Liquidia Corporation (LQDA) – Form 4 Insider-Meldung

Die Direktorin Dr. Joanna Horobin meldete am 17. Juni 2025 die Gewährung von 18.396 Restricted Stock Units (RSUs). Die Zuteilung wurde mit „A“ codiert, was einen Erwerb vom Emittenten und keinen Kauf am offenen Markt anzeigt. Die RSUs werden eins zu eins in Stammaktien umgewandelt und vesten entweder ein Jahr nach dem Zuteilungsdatum oder am Tag vor der nächsten jährlichen Hauptversammlung von Liquidia, je nachdem, was zuerst eintritt. Nach der Transaktion erhöhte sich Dr. Horobins gesamtes wirtschaftliches Eigentum auf 38.755 Aktien. Es wurde kein Geld ausgetauscht (Preis mit 0 $ angegeben), und es waren keine Derivate außer der RSU-Gewährung beteiligt.

Die Meldung stellt eine routinemäßige jährliche Aktienvergütung für Direktoren dar und enthält keine weiteren Käufe, Verkäufe oder Ausübungen von Optionen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine equity grant; negligible share dilution; neutral impact.

The Form 4 shows a standard non-cash RSU grant to a board member. At 18,396 shares, the issuance is immaterial relative to Liquidia’s total shares outstanding and therefore has limited valuation impact. Because the RSUs vest within a year or at the next AGM, the filing mainly signals ongoing director-to-shareholder alignment. No market purchases or sales were recorded, so there is no direct indicator of insider sentiment. Overall, this is a compliance disclosure with neutral financial consequences.

TL;DR: Standard director compensation; governance practices appear ordinary.

The grant structure—one-year or AGM-based vesting—matches common small-cap governance norms, encouraging short-term board engagement without imposing excessive dilution. The director now owns 38,755 shares, which modestly strengthens alignment but does not materially shift control dynamics. No Rule 10b5-1 plan was indicated. From a governance standpoint, the disclosure is routine and non-controversial.

Liquidia Corporation (LQDA) – Comunicazione interna Form 4

La direttrice Dott.ssa Joanna Horobin ha segnalato la concessione di 18.396 unità di azioni vincolate (RSU) il 17 giugno 2025. Il premio è stato codificato come “A”, indicando un’acquisizione dall’emittente e non un acquisto sul mercato aperto. Le RSU si convertono in azioni ordinarie con un rapporto uno a uno e matureranno alla prima delle seguenti condizioni: (i) un anno dalla data di concessione oppure (ii) il giorno precedente all’assemblea annuale degli azionisti di Liquidia. Dopo la transazione, la proprietà effettiva totale della Dott.ssa Horobin è salita a 38.755 azioni. Non è stato scambiato denaro (prezzo indicato pari a 0 $) e non sono stati coinvolti strumenti derivati oltre alla concessione delle RSU.

La comunicazione rappresenta una normale compensazione azionaria annuale per il direttore e non riporta ulteriori acquisti, vendite o esercizi di opzioni.

Liquidia Corporation (LQDA) – Presentación interna Formulario 4

La directora Dra. Joanna Horobin reportó la concesión de 18,396 unidades de acciones restringidas (RSU) el 17 de junio de 2025. La adjudicación fue codificada como “A”, lo que indica una adquisición del emisor y no una compra en el mercado abierto. Las RSU se convierten en acciones ordinarias en una proporción uno a uno y se consolidarán en la fecha que ocurra primero entre (i) un año desde la fecha de concesión o (ii) el día anterior a la próxima junta anual de accionistas de Liquidia. Tras la transacción, la propiedad total beneficiaria de la Dra. Horobin aumentó a 38,755 acciones. No se intercambió efectivo (precio reportado como $0) y no se involucraron valores derivados más allá de la concesión de las RSU.

La presentación representa la compensación anual rutinaria en acciones para directores y no revela compras, ventas o ejercicios de opciones adicionales.

Liquidia Corporation (LQDA) – 내부자 신고서 Form 4

이사 조안나 호로빈 박사가 2025년 6월 17일에 18,396개의 제한 주식 단위(RSU) 부여를 보고했습니다. 이 수여는 “A”로 분류되었으며, 이는 공개 시장에서의 구매가 아닌 발행자로부터의 취득을 의미합니다. RSU는 1대1 비율로 보통주로 전환되며, 부여일로부터 1년이 경과하거나 Liquidia의 다음 연례 주주총회 전날 중 빠른 날에 권리가 확정됩니다. 이번 거래 후 호로빈 박사의 총 실질 소유 주식 수는 38,755주로 증가했습니다. 현금 거래는 없었으며(보고된 가격은 0달러), RSU 부여 외에 파생 증권은 포함되지 않았습니다.

이번 신고는 정기적인 이사 연간 주식 보상에 해당하며, 추가 매수, 매도 또는 옵션 행사 내역은 포함하지 않습니다.

Liquidia Corporation (LQDA) – Déclaration d’initié Formulaire 4

La directrice Dr Joanna Horobin a déclaré la attribution de 18 396 unités d’actions restreintes (RSU) le 17 juin 2025. Cette attribution a été codée « A », indiquant une acquisition auprès de l’émetteur plutôt qu’un achat sur le marché libre. Les RSU se convertissent en actions ordinaires à raison d’une action pour une unité et seront acquises au plus tôt entre (i) un an à compter de la date d’attribution ou (ii) la veille de la prochaine assemblée annuelle des actionnaires de Liquidia. Suite à cette opération, la détention bénéficiaire totale de Dr Horobin est passée à 38 755 actions. Aucun échange d’argent n’a eu lieu (prix déclaré à 0 $), et aucun instrument dérivé n’a été impliqué en dehors de l’attribution des RSU.

Cette déclaration correspond à une rémunération annuelle courante en actions pour les administrateurs et ne révèle aucun achat, vente ou exercice d’option supplémentaire.

Liquidia Corporation (LQDA) – Form 4 Insider-Meldung

Die Direktorin Dr. Joanna Horobin meldete am 17. Juni 2025 die Gewährung von 18.396 Restricted Stock Units (RSUs). Die Zuteilung wurde mit „A“ codiert, was einen Erwerb vom Emittenten und keinen Kauf am offenen Markt anzeigt. Die RSUs werden eins zu eins in Stammaktien umgewandelt und vesten entweder ein Jahr nach dem Zuteilungsdatum oder am Tag vor der nächsten jährlichen Hauptversammlung von Liquidia, je nachdem, was zuerst eintritt. Nach der Transaktion erhöhte sich Dr. Horobins gesamtes wirtschaftliches Eigentum auf 38.755 Aktien. Es wurde kein Geld ausgetauscht (Preis mit 0 $ angegeben), und es waren keine Derivate außer der RSU-Gewährung beteiligt.

Die Meldung stellt eine routinemäßige jährliche Aktienvergütung für Direktoren dar und enthält keine weiteren Käufe, Verkäufe oder Ausübungen von Optionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Horobin Joanna

(Last) (First) (Middle)
419 DAVIS DRIVE, SUITE 100

(Street)
MORRISVILLE NC 27560

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Liquidia Corp [ LQDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A(1) 18,396(2) A $0 38,755 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
2. The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant.
/s/ Dr. Joanna Horobin 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Director Joanna Horobin acquire according to the LQDA Form 4?

The filing reports 18,396 RSUs acquired, convertible one-for-one into common stock.

What is Joanna Horobin's total beneficial ownership in Liquidia (LQDA) after the transaction?

After the grant, her beneficial ownership is 38,755 shares.

When do the newly granted LQDA RSUs vest?

They vest on the earlier of one year from 17 June 2025 or the day before Liquidia’s next annual shareholder meeting.

Was any cash paid for the RSUs reported in the Form 4?

No. The Form 4 lists the price as $0, indicating a non-cash equity award.

Does the filing indicate a Rule 10b5-1 trading plan?

No. The checkbox for a Rule 10b5-1(c) plan was left blank in the filing.
Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Latest SEC Filings

LQDA Stock Data

1.18B
71.79M
13.88%
61.4%
13.32%
Biotechnology
Pharmaceutical Preparations
Link
United States
MORRISVILLE